This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Mar 17;70(7):1418-1420.

doi: 10.1093/cid/ciz421.

Analytical Treatment Interruptions and Human Immunodeficiency Virus Cure Research: Seizing the Opportunity While Maintaining Safety and Respect

W David Hardy¹

Affiliations

PMID: 31102443
DOI: 10.1093/cid/ciz421

Comment

Analytical Treatment Interruptions and Human Immunodeficiency Virus Cure Research: Seizing the Opportunity While Maintaining Safety and Respect

W David Hardy. Clin Infect Dis. 2020.

. 2020 Mar 17;70(7):1418-1420.

doi: 10.1093/cid/ciz421.

Author

W David Hardy¹

Affiliation

¹ Division of Infectious Diseases, Johns Hopkins University School of Medicine, Washington, DC.

PMID: 31102443
DOI: 10.1093/cid/ciz421

No abstract available

Keywords: HIV cure; analytical treatment interruption (ATI); risk-benefit; test-of-cure.

PubMed Disclaimer

Comment on

Systematic Review and Meta-analysis of Treatment Interruptions in Human Immunodeficiency Virus (HIV) Type 1-infected Patients Receiving Antiretroviral Therapy: Implications for Future HIV Cure Trials.
Stecher M, Claßen A, Klein F, Lehmann C, Gruell H, Platten M, Wyen C, Behrens G, Fätkenheuer G, Vehreschild JJ. Stecher M, et al. Clin Infect Dis. 2020 Mar 17;70(7):1406-1417. doi: 10.1093/cid/ciz417. Clin Infect Dis. 2020. PMID: 31102444

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information